These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15588465)

  • 41. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: a statistical model-derived analysis.
    Gerli S; Bini V; Di Renzo GC
    Gynecol Endocrinol; 2008 Jan; 24(1):18-23. PubMed ID: 18224540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial.
    Danhof NA; van Wely M; Repping S; Koks C; Verhoeve HR; de Bruin JP; Verberg MFG; van Hooff MHA; Cohlen BJ; van Heteren CF; Fleischer K; Gianotten J; van Disseldorp J; Visser J; Broekmans FJM; Mol BWJ; van der Veen F; Mochtar MH;
    Hum Reprod; 2018 Oct; 33(10):1866-1874. PubMed ID: 30137325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial.
    Chen LJ; Liu Y; Zhang L; Li JY; Xiong WQ; Li T; Ding H; Li BJ
    Front Endocrinol (Lausanne); 2023; 14():1294339. PubMed ID: 38283747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome.
    Ertunc D; Tok EC; Savas A; Ozturk I; Dilek S
    Fertil Steril; 2010 Mar; 93(4):1179-84. PubMed ID: 19200979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of luteal phase support on gonadotropin ovulation induction cycles in patients with polycystic ovary syndrome.
    Yazici G; Savas A; Tasdelen B; Dilek S
    J Reprod Med; 2014; 59(1-2):25-30. PubMed ID: 24597283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles.
    Balasch J; Ballescá JL; Pimentel C; Creus M; Fábregues F; Vanrell JA
    Hum Reprod; 1994 Oct; 9(10):1863-6. PubMed ID: 7844217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization.
    Meden-Vrtovec H; Mocnik-Roznik S; Tomazevic T; Virant-Klun I
    J Reprod Med; 2003 Oct; 48(10):799-803. PubMed ID: 14619648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?
    Berkkanoglu M; Ozgur K
    Fertil Steril; 2010 Jul; 94(2):662-5. PubMed ID: 19368912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N; Sylvestre C; Tulandi T; Buckett W
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.
    Balasch J; Barri PN
    J Assist Reprod Genet; 2001 Feb; 18(2):45-55. PubMed ID: 11285980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.